Species differences in N-glucuronidation
- PMID: 9733661
Species differences in N-glucuronidation
Abstract
Glucuronidation of amines has been shown to exhibit species differences in vitro and in vivo. Substrates for N-glucuronidation can be classified according to the chemical structures of the resulting glucuronides into two groups: compounds that form non-quaternary N-conjugates, and those that form the quaternary counterparts. For compounds of the former class-such as sulfonamides, arylamines, and alicyclic, cyclic, and heterocyclic amines-species differences appear to be less striking and are of a quantitative nature. No one common laboratory animal species used routinely in metabolism research (e.g. rat, mouse, dog, non-human primate, rabbit, and guinea pig) has been shown to be deficient in N-glucuronidation when all of the substrates studied and reported are taken into consideration. The ability of a species to form N-glucuronides is compound-dependent, although rabbit and guinea pig appear to exhibit the highest capacity for this bioconjugation among preclinical species. For tertiary amines, most notably the tricyclic antidepressant and antihistamine drugs, N-glucuronidation is commonly observed in non-human primates and man. There are examples, however, of quaternary glucuronidation occurring in lower animal species. In exploring species differences in amine conjugation in vivo, it is noted that the apparent absence of N-glucuronides in animal urine may not reflect the inability of that species to form such conjugates, since the N-glucuronides may be excreted in bile. Problems such as degradation or low recoveries commonly encountered in isolation and identification of in vivo metabolites further complicate the interpretation of data. Because of the wide range of pKa values exhibited by various classes of amines, caution also should be exercised for in vitro studies since incubation conditions for N-glucuronidation often are substrate- and species-dependent. Explanations for the species differences observed in N-glucuronidation appear to be emerging as rapid advances are made in the understanding of the glucuronosyltransferases at the molecular level. More information, however, remains to be gathered from the glucuronosyltransferase genes of animal species other than humans before a better understanding of species differences in N-glucuronidation can be achieved.
Similar articles
-
Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins.Drug Metab Dispos. 1998 Sep;26(9):860-7. Drug Metab Dispos. 1998. PMID: 9733664 Review.
-
Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.Drug Metab Dispos. 1998 Jun;26(6):507-12. Drug Metab Dispos. 1998. PMID: 9616184
-
N+-glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group.Drug Metab Dispos. 1998 Sep;26(9):830-7. Drug Metab Dispos. 1998. PMID: 9733660 Review.
-
N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.Xenobiotica. 2011 Aug;41(8):652-69. doi: 10.3109/00498254.2011.563327. Epub 2011 Mar 24. Xenobiotica. 2011. PMID: 21434773 Review.
-
Species-dependent glucuronidation of drugs by immobilized rabbit, rhesus monkey, and human UDP-glucuronyltransferases.Drug Metab Dispos. 1987 Jul-Aug;15(4):473-7. Drug Metab Dispos. 1987. PMID: 2888619
Cited by
-
Development of a Population Pharmacokinetic Model Characterizing the Tissue Distribution of Resveratrol After Administration by Different Routes and Doses in Rats.Nutrients. 2025 Jan 3;17(1):181. doi: 10.3390/nu17010181. Nutrients. 2025. PMID: 39796615 Free PMC article.
-
Hyperthyroidism in cats: what's causing this epidemic of thyroid disease and can we prevent it?J Feline Med Surg. 2012 Nov;14(11):804-18. doi: 10.1177/1098612X12464462. J Feline Med Surg. 2012. PMID: 23087006 Free PMC article. Review.
-
Characterization of nuciferine metabolism by P450 enzymes and uridine diphosphate glucuronosyltransferases in liver microsomes from humans and animals.Acta Pharmacol Sin. 2010 Dec;31(12):1635-42. doi: 10.1038/aps.2010.172. Acta Pharmacol Sin. 2010. PMID: 21127497 Free PMC article.
-
Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation.Cancer Chemother Pharmacol. 2016 Dec;78(6):1225-1235. doi: 10.1007/s00280-016-3181-9. Epub 2016 Oct 24. Cancer Chemother Pharmacol. 2016. PMID: 27778071 Free PMC article.
-
Metabolite Profiling of Meridianin C In Vivo of Rat by UHPLC/Q-TOF MS.J Anal Methods Chem. 2021 Oct 21;2021:1382421. doi: 10.1155/2021/1382421. eCollection 2021. J Anal Methods Chem. 2021. PMID: 34721922 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources